Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $38.9800 (-4.11%) ($38.9100 - $41.1400) on Thu. Mar. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.86% (three month average) | RSI | 52 | Latest Price | $38.9800(-4.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.43% in a week (0% probabilities). VXX(-13%) UUP(-13%) TLT(-13%) VIXM(-11%) UNG(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.43% (StdDev 4.86%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
5 Day Moving Average | $38.56(1.09%) | 10 Day Moving Average | $38.26(1.88%) | 20 Day Moving Average | $38.46(1.35%) | To recent high | -6.6% | To recent low | 37.3% | Market Cap | $2.897b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |